Vital Signsby BridgeheadAll voices

01  Voice · Academic · Rare diseases

Benjamin Rome: no photograph is held, so the Program On Regulation, Therapeutics, And Law (PORTAL), Brigham and Women's Hospital / Harvard Medical School monogram is shown instead.
Academic

Benjamin Rome

Assistant Professor of Medicine, Harvard Medical School; Health Policy Researcher and Physician, Brigham and Women's Hospital, Program On Regulation, Therapeutics, And Law (PORTAL), Brigham and Women's Hospital / Harvard Medical School

Press coverage by month · bar height shows relative volume
Dec 2025Jan 2026FebMarAprMayJuneJulyAugSeptOctNovto date
1

Quoted in the press, across 1 topic since 3 Oct 2025

OfficeProgram On Regulation, Therapeutics, And Law (PORTAL), Brigham and Women's Hospital / Harvard Medical School, Boston, MA, USA, 02115The organisation’s office, not a personal address.

02  Quoted on · 1 of 29 topics

Open the topic

Benjamin Rome: key facts

Kind of voice
Academic
Role
Assistant Professor of Medicine, Harvard Medical School; Health Policy Researcher and Physician, Brigham and Women's Hospital
Organisation
Program On Regulation, Therapeutics, And Law (PORTAL), Brigham and Women's Hospital / Harvard Medical School
Quoted on
Rare diseases
Press coverage
Quoted in the press
Most recently quoted
8 Aug 2026
First quoted
3 Oct 2025

03  Profile

Who Benjamin Rome is

Benjamin N. Rome, MD, MPH, is an Assistant Professor of Medicine at Harvard Medical School and a faculty member of PORTAL, based in the Division of Pharmacoepidemiology and Pharmacoeconomics at Brigham and Women's Hospital.

He is a general internist and practising primary care physician. His research examines how federal and state policies influence the regulation, use and cost of prescription drugs, and the effects on patient access, affordability and clinical outcomes. His work has been published in the New England Journal of Medicine, JAMA, Health Affairs and BMJ.

He has testified before US House committees on drug regulation and prices. He holds a Brown University degree in community health, an MD from Harvard Medical School, and an MPH from the Harvard T.H. Chan School of Public Health.

He is a US-based researcher, so his comments relate to the US system. I did not find or verify any specific UK press quotes.

Notable achievements

  1. 01

    Selected as an Emerging Leaders in Health and Medicine Scholar by the National Academy of Medicine in 2022 Source ↗

  2. 02

    Testified to the US House Ways and Means Committee on the causes of unaffordable prescription drugs (2023) Source ↗

  3. 03

    Testified to the US House Science Committee's Investigations and Oversight Subcommittee on drug approval during the Covid-19 pandemic (2020) Source ↗

  4. 04

    Corresponding author of a JAMA research letter finding that launch prices of 548 newly marketed brand-name drugs (2008-2021) rose by more than 20% a year on average Source ↗

  5. 05

    Site Co-Director of the HMS Fellowship in General Medicine and Primary Care Source ↗

04  The signal · where Benjamin Rome sits on rare diseases

Quoted

Quoted in the press on rare diseases.

Placed by press coverage on this topic only, not across all topics.

  1. Giles LomaxSector leaderChief Executive Officer, Spinal Muscular Atrophy UK (SMA UK)Leading
  2. Dr Harrison CarterAcademicDirector of Screening at NHS EnglandLeading
  3. Dr Rich ScottSector leaderChief Executive Officer of Genomics EnglandLeading
  4. Kirsty CampbellCliniciancharge nurse; mother of Mollie Murray
  5. Dr Eva IoannidouClinicianAction Medical Research Training Fellow and Doctoral Clinical Research Fellow at UCL Great Ormond Street Institute of Child Health
  6. Benjamin RomeAcademicAssistant Professor of Medicine, Harvard Medical School; Health Policy Researcher and Physician, Brigham and Women's Hospital, Program On Regulation, Therapeutics, And Law (PORTAL), Brigham and Women's Hospital / Harvard Medical School
  7. Timothy Yu, MD, PhDClinicianAttending Physician, Division of Genetics and Genomics; Associate Professor of Pediatrics, Harvard Medical School, Boston Children's Hospital
  8. Wendy Chung, MD, PhDClinicianChief, Department of Pediatrics (Physician-in-Chief), Boston Children's Hospital

Showing the leading voices and those placed around Benjamin Rome · See every voice on the topic →

05  On the record · press

What Benjamin Rome has said

By outlet · bar length shows relative volume
  • biospace.com
  • medicaldaily.com

Where Benjamin Rome has been quoted

  1. Exempting Rare Disease Drugs Would Erase Most Savings from a Medicare Price Pilot, Analysis Findsmedicaldaily.com · 8 Aug 2026
  2. CMS Finalizes Stronger Protections for Orphan Drugs Against IRA Price Negotiationsbiospace.com · 3 Oct 2025

How we found the articles that name Benjamin Rome: we searched news for these terms.

  • rare disease
  • rare conditions
  • orphan drugs
  • genetic disorder
  • cystic fibrosis
  • motor neurone disease
  • muscular dystrophy
  • Huntington

Also searched with “rare disease” in each of 8 national papers. Every term for Rare diseases

Verbatim

“Harvard Medical School researchers Benjamin Rome and Aaron Kesselheim, who have published repeatedly on this question, have argued that expanding the exemption would unnecessarily limit the number of eligible drugs while allowing continued high prices for products earning billions in Medicare.”
Harvard Medical School researcher · Rare diseases · medicaldaily.com · 8 Aug 2026 · Read the article
“Even a one-year delay in negotiating the prices for those drugs will be extraordinarily consequential”
Harvard healthy policy researcher · Rare diseases · biospace.com · 3 Oct 2025 · Read the article

Related media coverage

Recent UK press coverage of their topics, not necessarily citing them directly.

06  Sources

References for this biography

  1. Benjamin N. Rome, MD, MPH – PORTAL. Current title, research focus, publications, 2022 NAM scholar award, fellowship co-director role, education, and PORTAL address (41 Avenue Louis Pasteur, Boston MA 02115)
  2. Benjamin Rome – PORTAL: Program on Regulation, Therapeutics, and Law. Roles at HMS and Brigham and Women's, US House testimony, primary care practice, and education
  3. Benjamin Rome – Harvard Medical School Professional, Corporate, and Continuing Education. Titles: Assistant Professor of Medicine at HMS; Health Policy Researcher and Physician at Brigham and Women's Hospital
  4. Benjamin Rome – LinkedIn. LinkedIn profile for a Harvard Medical School assistant professor and primary care physician and health policy researcher on prescription drugs. Its education and publications match the other sources.
  5. Testimony of Benjamin N. Rome, House Ways and Means Committee. 2023 testimony on unaffordable prescription drugs and his argument that US drug makers are free to set and raise prices during government-granted monopolies
  6. Testimony of Benjamin N. Rome, House Science Committee, 19 June 2020. 2020 testimony on drug approval during the Covid-19 pandemic
  7. BWH Research Brief – Prices for newly marketed brand-name drugs skyrocket. JAMA research letter on launch prices of new brand-name drugs and his comments on US drug pricing reform
  8. Why does your prescription cost so much? A Mass General Brigham expert explains. Description of his research on patents, competition, insurance coverage and government policy in drug pricing

07  Contact & links

LinkedIn
linkedin.com/in/bnromepublished here ↗
Staff page
portalresearch.org/team/benjamin-rome
Staff page
learn.hms.harvard.edu/about/leadership-faculty/profile/benjamin-rome
Website
portalresearch.org/benjamin-rome.html

Organisational contact points only, each taken from a page the organisation publishes itself. No personal or direct contact details are held or shown.

Professors, researchers and think-tank analysts quoted on the strength of their research rather than a clinical role. Citations are counted by an automated scan of UK press coverage and may be incomplete. Roles, biographies and contact details are researched and human-reviewed before they appear here; anything not yet reviewed is simply absent rather than shown unverified. This profile was last updated on 3 Nov 2026. See the methodology for how this page is built, or email contact@bridgeheadcommunications.com to correct anything on it.